International Stem Cell (ISCO) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
International Stem Cell (ISCO) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 39.88% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 68.53% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 162.14% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -102.31% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 515.34% |
| 10 | International Stem Cell | 3.36 Mn | 2.27 Mn | 1.46 Mn | -205.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -205.97% |
| Dec 31, 2025 | -3,000.00% |
| Sep 30, 2025 | 123.20% |
| Jun 30, 2025 | 8.06% |
| Mar 31, 2025 | -19.63% |
| Dec 31, 2024 | 102.62% |
| Sep 30, 2024 | 4.58% |
| Jun 30, 2024 | -76.06% |
| Mar 31, 2024 | -529.38% |
| Dec 31, 2023 | -1,735.63% |
| Sep 30, 2023 | 61.81% |
| Jun 30, 2023 | 13,049.37% |
| Mar 31, 2023 | -277.78% |
| Dec 31, 2022 | 107.53% |
| Sep 30, 2022 | 46.49% |
| Jun 30, 2022 | 99.56% |
| Mar 31, 2022 | 98.58% |
| Dec 31, 2021 | 53.96% |
| Sep 30, 2021 | 26.91% |
| Jun 30, 2021 | 49.83% |